{"transactions":[{"id":4636914,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-07T19:45:26.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":17800,"price":7.09,"value":126202.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to\nthe vesting of RSUs on October 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":111921,"source":{"system":"sec-edgar","filing":"0001583098-26-000008","document":"wk-form4_1791402323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583098/000158309826000008/wk-form4_1791402323.xml","form_type":"4"}},{"id":4629247,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-10-05T13:16:26.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":6.53,"value":19590.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.52 to $6.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":156098,"source":{"system":"sec-edgar","filing":"0001961994-26-000029","document":"wk-form4_1791206183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1961994/000196199426000029/wk-form4_1791206183.xml","form_type":"4"}},{"id":717461,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-07-02T16:57:23.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":8.4,"value":25200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":159098,"source":{"system":"sec-edgar","filing":"0001961994-26-000024","document":"wk-form4_1783011439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000024/wk-form4_1783011439.xml","form_type":"4"}},{"id":742826,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-06-10T19:09:20.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":694,"price":8,"value":5552.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":162098,"source":{"system":"sec-edgar","filing":"0001961994-26-000021","document":"wk-form4_1781118557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000021/wk-form4_1781118557.xml","form_type":"4"}},{"id":742904,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T19:08:23.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":3964,"price":8,"value":31712.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":374083,"source":{"system":"sec-edgar","filing":"0001196632-26-000017","document":"wk-form4_1781118501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000017/wk-form4_1781118501.xml","form_type":"4"}},{"id":742825,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-06-10T19:07:09.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2018,"price":8,"value":16144.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":202201,"source":{"system":"sec-edgar","filing":"0001919170-26-000016","document":"wk-form4_1781118426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000016/wk-form4_1781118426.xml","form_type":"4"}},{"id":742824,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2026-06-10T19:05:39.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1741,"price":8,"value":13928.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":185558,"source":{"system":"sec-edgar","filing":"0001989644-26-000011","document":"wk-form4_1781118336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000011/wk-form4_1781118336.xml","form_type":"4"}},{"id":793593,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:30:54.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001536908-26-000004","document":"wk-form4_1777930251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000153690826000004/wk-form4_1777930251.xml","form_type":"4"}},{"id":793592,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:54.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":980,"price":8.94,"value":8761.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 8, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.70 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":100563,"source":{"system":"sec-edgar","filing":"0001536908-26-000004","document":"wk-form4_1777930251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000153690826000004/wk-form4_1777930251.xml","form_type":"4"}},{"id":793591,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:54.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":12781,"price":8.36,"value":106849.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 8, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.70 to $8.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":101543,"source":{"system":"sec-edgar","filing":"0001536908-26-000004","document":"wk-form4_1777930251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000153690826000004/wk-form4_1777930251.xml","form_type":"4"}},{"id":793590,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:54.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":114324,"source":{"system":"sec-edgar","filing":"0001536908-26-000004","document":"wk-form4_1777930251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000153690826000004/wk-form4_1777930251.xml","form_type":"4"}},{"id":793589,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:30:24.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793588,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":954,"price":8.96,"value":8547.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.80 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":129721,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793587,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":14527,"price":8.36,"value":121445.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":130675,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793586,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":145202,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793610,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49925,"kind":"person","name":"Katkin Keith","position":1,"cik":"0001314596","reported_name":"Katkin Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-05-04T21:29:30.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001314596-26-000002","document":"wk-form4_1777930168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314596/000131459626000002/wk-form4_1777930168.xml","form_type":"4"}},{"id":793609,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49925,"kind":"person","name":"Katkin Keith","position":1,"cik":"0001314596","reported_name":"Katkin Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:29:30.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":15481,"price":8.28,"value":128182.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated November 10, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.23 to $8.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":96294,"source":{"system":"sec-edgar","filing":"0001314596-26-000002","document":"wk-form4_1777930168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314596/000131459626000002/wk-form4_1777930168.xml","form_type":"4"}},{"id":793608,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49925,"kind":"person","name":"Katkin Keith","position":1,"cik":"0001314596","reported_name":"Katkin Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:29:30.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the Reporting Person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":111775,"source":{"system":"sec-edgar","filing":"0001314596-26-000002","document":"wk-form4_1777930168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314596/000131459626000002/wk-form4_1777930168.xml","form_type":"4"}},{"id":793770,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:29:14.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001493324-26-000002","document":"wk-form4_1777930151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493324/000149332426000002/wk-form4_1777930151.xml","form_type":"4"}},{"id":793769,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:29:14.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the Reporting Person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":113839,"source":{"system":"sec-edgar","filing":"0001493324-26-000002","document":"wk-form4_1777930151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493324/000149332426000002/wk-form4_1777930151.xml","form_type":"4"}},{"id":793624,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49927,"kind":"person","name":"FOWLER JOHN D JR","position":1,"cik":"0001190344","reported_name":"FOWLER JOHN D JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:29:00.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001190344-26-000012","document":"wk-form4_1777930137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190344/000119034426000012/wk-form4_1777930137.xml","form_type":"4"}},{"id":793623,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49927,"kind":"person","name":"FOWLER JOHN D JR","position":1,"cik":"0001190344","reported_name":"FOWLER JOHN D JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:29:00.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":30350,"source":{"system":"sec-edgar","filing":"0001190344-26-000012","document":"wk-form4_1777930137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190344/000119034426000012/wk-form4_1777930137.xml","form_type":"4"}},{"id":793583,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:28:53.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001380177-26-000004","document":"wk-form4_1777930129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017726000004/wk-form4_1777930129.xml","form_type":"4"}},{"id":793582,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:53.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":123761,"source":{"system":"sec-edgar","filing":"0001380177-26-000004","document":"wk-form4_1777930129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017726000004/wk-form4_1777930129.xml","form_type":"4"}},{"id":793858,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:28:00.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793857,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1057,"price":8.97,"value":9481.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.79 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":79941,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793856,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":16145,"price":8.36,"value":134972.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.77 to $8.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":80998,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793855,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":97143,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793772,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:27:43.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001493692-26-000003","document":"wk-form4_1777930061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000149369226000003/wk-form4_1777930061.xml","form_type":"4"}},{"id":793771,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:27:43.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":160847,"source":{"system":"sec-edgar","filing":"0001493692-26-000003","document":"wk-form4_1777930061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000149369226000003/wk-form4_1777930061.xml","form_type":"4"}},{"id":793585,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:23:51.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001380184-26-000005","document":"wk-form4_1777929828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138018426000005/wk-form4_1777929828.xml","form_type":"4"}},{"id":793584,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock","published_at":"2026-05-04T21:23:51.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":149076,"source":{"system":"sec-edgar","filing":"0001380184-26-000005","document":"wk-form4_1777929828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138018426000005/wk-form4_1777929828.xml","form_type":"4"}},{"id":795351,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-05-01T20:30:14.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":100111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the  anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":162792,"source":{"system":"sec-edgar","filing":"0001961994-26-000017","document":"wk-form4_1777667409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000017/wk-form4_1777667409.xml","form_type":"4"}},{"id":795936,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50356,"kind":"person","name":"Lowry Simon C","position":1,"cik":"0002044279","reported_name":"Lowry Simon C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D, CMO"}}],"security":"Common Stock","published_at":"2026-05-01T20:29:33.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":100111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":177914,"source":{"system":"sec-edgar","filing":"0002044279-26-000007","document":"wk-form4_1777667370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044279/000204427926000007/wk-form4_1777667370.xml","form_type":"4"}},{"id":795352,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-05-01T20:28:50.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":100111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":204219,"source":{"system":"sec-edgar","filing":"0001919170-26-000012","document":"wk-form4_1777667327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000012/wk-form4_1777667327.xml","form_type":"4"}},{"id":795389,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:27:42.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":162680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":378047,"source":{"system":"sec-edgar","filing":"0001196632-26-000013","document":"wk-form4_1777667258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000013/wk-form4_1777667258.xml","form_type":"4"}},{"id":795928,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50355,"kind":"person","name":"Perl Jessica","position":1,"cik":"0002043716","reported_name":"Perl Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-05-01T20:27:23.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":104282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the  anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":165286,"source":{"system":"sec-edgar","filing":"0002043716-26-000007","document":"wk-form4_1777667240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043716/000204371626000007/wk-form4_1777667240.xml","form_type":"4"}},{"id":795350,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2026-05-01T20:26:54.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":100111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":187299,"source":{"system":"sec-edgar","filing":"0001989644-26-000007","document":"wk-form4_1777667211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000007/wk-form4_1777667211.xml","form_type":"4"}},{"id":795404,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-01T20:26:19.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":187708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the  anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":493153,"source":{"system":"sec-edgar","filing":"0001242215-26-000012","document":"wk-form4_1777667176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000012/wk-form4_1777667176.xml","form_type":"4"}},{"id":815898,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-04-03T20:05:55.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":8.44,"value":33760.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.34 to $8.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62681,"source":{"system":"sec-edgar","filing":"0001961994-26-000013","document":"wk-form4_1775246752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000013/wk-form4_1775246752.xml","form_type":"4"}},{"id":855632,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T13:50:53.000Z","date":"2026-02-25","kind":"other","planned":false,"acquired":false,"shares":20321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported stock options expired unexercised pursuant to their terms and no value was received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested in three equal installments beginning on the day prior to the first anniversary of the date of grant, subject to continued service with the company."}],"balance_after":0,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":20321},"source":{"system":"sec-edgar","filing":"0001196632-26-000011","document":"wk-form4_1772805051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000011/wk-form4_1772805051.xml","form_type":"4"}},{"id":855631,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T13:50:53.000Z","date":"2025-05-07","kind":"other","planned":false,"acquired":false,"shares":19963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported stock options expired unexercised pursuant to their terms and no value was received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vested in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":48.33,"expiration_date":"2025-05-07","underlying":"Common Stock","underlying_shares":19963},"source":{"system":"sec-edgar","filing":"0001196632-26-000011","document":"wk-form4_1772805051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000011/wk-form4_1772805051.xml","form_type":"4"}},{"id":858086,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:40:29.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":252194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":1784694,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":252194},"source":{"system":"sec-edgar","filing":"0001242215-26-000008","document":"wk-form4_1772764826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000008/wk-form4_1772764826.xml","form_type":"4"}},{"id":858085,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-06T02:40:29.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":37055,"price":8.44,"value":312744.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of performance stock units."}],"balance_after":305445,"source":{"system":"sec-edgar","filing":"0001242215-26-000008","document":"wk-form4_1772764826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000008/wk-form4_1772764826.xml","form_type":"4"}},{"id":858069,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49927,"kind":"person","name":"FOWLER JOHN D JR","position":1,"cik":"0001190344","reported_name":"FOWLER JOHN D JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T02:38:11.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":5006,"price":8.99,"value":45003.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the  anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":5006,"source":{"system":"sec-edgar","filing":"0001190344-26-000010","document":"wk-form4_1772764688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190344/000119034426000010/wk-form4_1772764688.xml","form_type":"4"}},{"id":859050,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50356,"kind":"person","name":"Lowry Simon C","position":1,"cik":"0002044279","reported_name":"Lowry Simon C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D, CMO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:21:35.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":44834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":147833,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":44834},"source":{"system":"sec-edgar","filing":"0002044279-26-000003","document":"wk-form4_1772763692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2044279/000204427926000003/wk-form4_1772763692.xml","form_type":"4"}},{"id":859049,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50356,"kind":"person","name":"Lowry Simon C","position":1,"cik":"0002044279","reported_name":"Lowry Simon C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D, CMO"}}],"security":"Common Stock","published_at":"2026-03-06T02:21:35.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":10636,"price":8.44,"value":89767.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":77803,"source":{"system":"sec-edgar","filing":"0002044279-26-000003","document":"wk-form4_1772763692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044279/000204427926000003/wk-form4_1772763692.xml","form_type":"4"}},{"id":858018,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:20:01.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":44834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":259545,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":44834},"source":{"system":"sec-edgar","filing":"0001989644-26-000005","document":"wk-form4_1772763598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000005/wk-form4_1772763598.xml","form_type":"4"}},{"id":858017,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2026-03-06T02:20:01.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":9493,"price":8.44,"value":80120.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":87188,"source":{"system":"sec-edgar","filing":"0001989644-26-000005","document":"wk-form4_1772763598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000005/wk-form4_1772763598.xml","form_type":"4"}},{"id":859046,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50355,"kind":"person","name":"Perl Jessica","position":1,"cik":"0002043716","reported_name":"Perl Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel, Corp Sec"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:19:36.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":46702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":142647,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":46702},"source":{"system":"sec-edgar","filing":"0002043716-26-000005","document":"wk-form4_1772763573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043716/000204371626000005/wk-form4_1772763573.xml","form_type":"4"}},{"id":859045,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50355,"kind":"person","name":"Perl Jessica","position":1,"cik":"0002043716","reported_name":"Perl Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-06T02:19:36.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6465,"price":8.44,"value":54564.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":61004,"source":{"system":"sec-edgar","filing":"0002043716-26-000005","document":"wk-form4_1772763573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043716/000204371626000005/wk-form4_1772763573.xml","form_type":"4"}},{"id":858016,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:08:56.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":44834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":254948,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":44834},"source":{"system":"sec-edgar","filing":"0001961994-26-000009","document":"wk-form4_1772762934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000009/wk-form4_1772762934.xml","form_type":"4"}},{"id":858015,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-03-06T02:08:56.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":9397,"price":8.44,"value":79310.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":66681,"source":{"system":"sec-edgar","filing":"0001961994-26-000009","document":"wk-form4_1772762934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000009/wk-form4_1772762934.xml","form_type":"4"}},{"id":858068,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:07:03.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":72856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":557346,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":72856},"source":{"system":"sec-edgar","filing":"0001196632-26-000009","document":"wk-form4_1772762821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000009/wk-form4_1772762821.xml","form_type":"4"}},{"id":858067,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T02:07:03.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":23650,"price":8.44,"value":199606.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":215367,"source":{"system":"sec-edgar","filing":"0001196632-26-000009","document":"wk-form4_1772762821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000009/wk-form4_1772762821.xml","form_type":"4"}},{"id":858013,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:06:04.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":44834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":294447,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":44834},"source":{"system":"sec-edgar","filing":"0001919170-26-000009","document":"wk-form4_1772762761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000009/wk-form4_1772762761.xml","form_type":"4"}},{"id":858012,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-03-06T02:06:04.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":8199,"price":8.44,"value":69199.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":104108,"source":{"system":"sec-edgar","filing":"0001919170-26-000009","document":"wk-form4_1772762761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000009/wk-form4_1772762761.xml","form_type":"4"}},{"id":865737,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-03-03T21:33:20.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":116,"price":8.15,"value":945.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":76078,"source":{"system":"sec-edgar","filing":"0001961994-26-000006","document":"wk-form4_1772573590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000006/wk-form4_1772573590.xml","form_type":"4"}},{"id":865937,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:32:31.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":8.15,"value":5566.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":239017,"source":{"system":"sec-edgar","filing":"0001196632-26-000006","document":"wk-form4_1772573548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000006/wk-form4_1772573548.xml","form_type":"4"}},{"id":865734,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-03-03T21:16:51.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":313,"price":8.15,"value":2550.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":112307,"source":{"system":"sec-edgar","filing":"0001919170-26-000006","document":"wk-form4_1772572600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000006/wk-form4_1772572600.xml","form_type":"4"}},{"id":912442,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50355,"kind":"person","name":"Perl Jessica","position":1,"cik":"0002043716","reported_name":"Perl Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-02-11T00:11:20.000Z","date":"2026-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":918,"price":11.03,"value":10125.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":67469,"source":{"system":"sec-edgar","filing":"0002043716-26-000002","document":"wk-form4_1770768677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043716/000204371626000002/wk-form4_1770768677.xml","form_type":"4"}},{"id":911521,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-02-11T00:09:25.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":2852,"price":10.92,"value":31143.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":112620,"source":{"system":"sec-edgar","filing":"0001919170-26-000003","document":"wk-form4_1770768563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000003/wk-form4_1770768563.xml","form_type":"4"}},{"id":911520,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2026-02-11T00:09:25.000Z","date":"2026-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28847,"price":10.92,"value":315009.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 9,615 shares of common stock, which is less than the 38,462 shares previously reported on March 02, 2023 and June 09, 2023."}],"balance_after":115472,"source":{"system":"sec-edgar","filing":"0001919170-26-000003","document":"wk-form4_1770768563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917026000003/wk-form4_1770768563.xml","form_type":"4"}},{"id":911519,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-02-11T00:07:24.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1022,"price":10.92,"value":11160.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":76194,"source":{"system":"sec-edgar","filing":"0001961994-26-000003","document":"wk-form4_1770768441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000003/wk-form4_1770768441.xml","form_type":"4"}},{"id":911518,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2026-02-11T00:07:24.000Z","date":"2026-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8655,"price":10.92,"value":94512.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 2,884 shares of common stock, which is less than the 11,539 shares previously reported on March 02, 2023 and June 09, 2023."}],"balance_after":77216,"source":{"system":"sec-edgar","filing":"0001961994-26-000003","document":"wk-form4_1770768441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000196199426000003/wk-form4_1770768441.xml","form_type":"4"}},{"id":911517,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:54.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":630,"price":10.92,"value":6879.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":96681,"source":{"system":"sec-edgar","filing":"0001989644-26-000002","document":"wk-form4_1770768411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000002/wk-form4_1770768411.xml","form_type":"4"}},{"id":911516,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:54.000Z","date":"2026-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5771,"price":10.92,"value":63019.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 1,922 shares of common stock, which is less than the 7,693 shares previously reported on March 02, 2023 and June 09, 2023."}],"balance_after":97311,"source":{"system":"sec-edgar","filing":"0001989644-26-000002","document":"wk-form4_1770768411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964426000002/wk-form4_1770768411.xml","form_type":"4"}},{"id":911580,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5642,"price":10.92,"value":61610.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":239700,"source":{"system":"sec-edgar","filing":"0001196632-26-000003","document":"wk-form4_1770768376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000003/wk-form4_1770768376.xml","form_type":"4"}},{"id":911579,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:19.000Z","date":"2026-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46155,"price":10.92,"value":504012.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 15,384 shares of common stock, which is less than the 61,539 shares previously reported on March 02, 2023 and June 09, 2023."}],"balance_after":245342,"source":{"system":"sec-edgar","filing":"0001196632-26-000003","document":"wk-form4_1770768376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000003/wk-form4_1770768376.xml","form_type":"4"}},{"id":967951,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":50356,"kind":"person","name":"Lowry Simon C","position":1,"cik":"0002044279","reported_name":"Lowry Simon C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D, CMO"}}],"security":"Common Stock","published_at":"2025-12-16T21:12:17.000Z","date":"2025-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":3543,"price":11.41,"value":40425.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":88439,"source":{"system":"sec-edgar","filing":"0002044279-25-000003","document":"wk-form4_1765919534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044279/000204427925000003/wk-form4_1765919534.xml","form_type":"4"}},{"id":975720,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":false,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, as compensation for Board and Committee service. The shares underlying the options exercised were fully vested on May 22, 2025."}],"balance_after":0,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975719,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":14884,"price":11.8978,"value":177086.8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97."}],"balance_after":98417,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975718,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":10864,"price":11.8978,"value":129257.6992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock sold solely to satisfy the option exercise price and applicable taxes associated with the option exercise."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97."}],"balance_after":113301,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975717,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":true,"shares":25748,"price":5.02,"value":129254.96,"ownership":{"direct":true},"balance_after":124165,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975716,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":7100,"price":12.1113,"value":85990.23,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12."}],"balance_after":98417,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":999958,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2025-11-13T21:01:27.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":610,"price":10.88,"value":6636.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":103082,"source":{"system":"sec-edgar","filing":"0001989644-25-000006","document":"wk-form4_1763067684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000198964425000006/wk-form4_1763067684.xml","form_type":"4"}},{"id":1001695,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:13:07.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":17801,"price":10.54,"value":187622.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":119858,"source":{"system":"sec-edgar","filing":"0001583098-25-000005","document":"wk-form4_1762981979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309825000005/wk-form4_1762981979.xml","form_type":"4"}},{"id":1003501,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T21:09:22.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":8552,"price":10,"value":85520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on August 8, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $10.00."}],"balance_after":88980,"source":{"system":"sec-edgar","filing":"0001536908-25-000006","document":"wk-form4_1762808960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000153690825000006/wk-form4_1762808960.xml","form_type":"4"}},{"id":1016439,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-17T20:02:38.000Z","date":"2025-10-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4995,"price":9.6,"value":47952.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":291497,"source":{"system":"sec-edgar","filing":"0001196632-25-000004","document":"wk-form4_1760731355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663225000004/wk-form4_1760731355.xml","form_type":"4"}},{"id":1017461,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2025-10-16T20:21:21.000Z","date":"2025-10-07","kind":"sale","planned":false,"acquired":false,"shares":30608,"price":10,"value":306080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 2, 2024 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $10.00."}],"balance_after":144319,"source":{"system":"sec-edgar","filing":"0001919170-25-000004","document":"wk-form4_1760646078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000191917025000004/wk-form4_1760646078.xml","form_type":"4"}},{"id":1063928,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-18T20:33:31.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":7086,"price":8.87,"value":62852.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating\nto the vesting of RSUs on May 22, 2025 and May 25, 2025, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $8.87."}],"balance_after":71799,"source":{"system":"sec-edgar","filing":"0001628280-25-040670","document":"wk-form4_1755549206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000162828025040670/wk-form4_1755549206.xml","form_type":"4"}},{"id":1067632,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T20:22:58.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":7844,"price":8.6475,"value":67830.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $8.6475."}],"balance_after":137659,"source":{"system":"sec-edgar","filing":"0001628280-25-040156","document":"wk-form4_1755116574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000162828025040156/wk-form4_1755116574.xml","form_type":"4"}},{"id":1087268,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2025-07-15T20:04:10.000Z","date":"2025-07-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4263,"price":7.36,"value":31375.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":103692,"source":{"system":"sec-edgar","filing":"0001367644-25-000166","document":"wk-form4_1752609846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000166/wk-form4_1752609846.xml","form_type":"4"}},{"id":1116068,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39594,"kind":"person","name":"Hartzel William","position":1,"cik":"0001989644","reported_name":"Hartzel William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Bioservices"}}],"security":"Common Stock","published_at":"2025-06-10T20:12:45.000Z","date":"2025-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1167,"price":6.63,"value":7737.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":107955,"source":{"system":"sec-edgar","filing":"0001367644-25-000144","document":"wk-form4_1749586359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000144/wk-form4_1749586359.xml","form_type":"4"}},{"id":1116067,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39595,"kind":"person","name":"Glessner Coleen","position":1,"cik":"0001919170","reported_name":"Glessner Coleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Quality & Ethics, and CPL"}}],"security":"Common Stock","published_at":"2025-06-10T20:12:36.000Z","date":"2025-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1249,"price":6.63,"value":8280.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":174927,"source":{"system":"sec-edgar","filing":"0001367644-25-000143","document":"wk-form4_1749586350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000143/wk-form4_1749586350.xml","form_type":"4"}},{"id":1116066,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":32697,"kind":"person","name":"Williams Paul Anthony","position":1,"cik":"0001961994","reported_name":"Williams Paul Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Products Business"}}],"security":"Common Stock","published_at":"2025-06-10T20:12:27.000Z","date":"2025-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":464,"price":6.63,"value":3076.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":85871,"source":{"system":"sec-edgar","filing":"0001367644-25-000142","document":"wk-form4_1749586339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000142/wk-form4_1749586339.xml","form_type":"4"}},{"id":1116138,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T20:07:00.000Z","date":"2025-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2733,"price":6.63,"value":18119.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":296492,"source":{"system":"sec-edgar","filing":"0001367644-25-000138","document":"wk-form4_1749586014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000138/wk-form4_1749586014.xml","form_type":"4"}},{"id":1131649,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49925,"kind":"person","name":"Katkin Keith","position":1,"cik":"0001314596","reported_name":"Katkin Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T20:08:23.000Z","date":"2025-05-23","kind":"sale","planned":true,"acquired":false,"shares":7844,"price":6.3,"value":49417.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated November 8, 2024, for the purpose of satisfying tax obligations relating to the vesting of RSUs on May 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $6.22 - $6.35. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":86431,"source":{"system":"sec-edgar","filing":"0001367644-25-000136","document":"wk-form4_1748462897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314596/000136764425000136/wk-form4_1748462897.xml","form_type":"4"}},{"id":1147182,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-15T20:02:40.000Z","date":"2025-05-13","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":5.83,"value":349800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 13, 2025, Mr. Papa purchased an aggregate of 60,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, purchase prices within a $1 range have been aggregated and the weighted average purchase price has been reported. The price ranges were: $5.76 - $5.88. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":342500,"source":{"system":"sec-edgar","filing":"0001367644-25-000127","document":"wk-form4_1747339349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000127/wk-form4_1747339349.xml","form_type":"4"}},{"id":1160826,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:43.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000111","document":"wk-form4_1746232297.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000111/wk-form4_1746232297.xml","form_type":"4"}},{"id":1160825,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:43.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":105517,"source":{"system":"sec-edgar","filing":"0001367644-25-000111","document":"wk-form4_1746232297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000111/wk-form4_1746232297.xml","form_type":"4"}},{"id":1161134,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:33.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000110","document":"wk-form4_1746232287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493324/000136764425000110/wk-form4_1746232287.xml","form_type":"4"}},{"id":1161133,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25014,"kind":"person","name":"White Marvin L","position":1,"cik":"0001493324","reported_name":"White Marvin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:33.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":88495,"source":{"system":"sec-edgar","filing":"0001367644-25-000110","document":"wk-form4_1746232287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493324/000136764425000110/wk-form4_1746232287.xml","form_type":"4"}},{"id":1161136,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:22.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000109","document":"wk-form4_1746232276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764425000109/wk-form4_1746232276.xml","form_type":"4"}},{"id":1161135,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:22.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":135503,"source":{"system":"sec-edgar","filing":"0001367644-25-000109","document":"wk-form4_1746232276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764425000109/wk-form4_1746232276.xml","form_type":"4"}},{"id":1161189,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000108","document":"wk-form4_1746232265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764425000108/wk-form4_1746232265.xml","form_type":"4"}},{"id":1161188,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":78885,"source":{"system":"sec-edgar","filing":"0001367644-25-000108","document":"wk-form4_1746232265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764425000108/wk-form4_1746232265.xml","form_type":"4"}},{"id":1160824,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:01.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000107","document":"wk-form4_1746232253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000107/wk-form4_1746232253.xml","form_type":"4"}},{"id":1160823,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49919,"kind":"person","name":"Dayal Sujata Tyagi","position":1,"cik":"0001536908","reported_name":"Dayal Sujata Tyagi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:01.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":97532,"source":{"system":"sec-edgar","filing":"0001367644-25-000107","document":"wk-form4_1746232253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000107/wk-form4_1746232253.xml","form_type":"4"}},{"id":1160857,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49925,"kind":"person","name":"Katkin Keith","position":1,"cik":"0001314596","reported_name":"Katkin Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:30:49.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000106","document":"wk-form4_1746232243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314596/000136764425000106/wk-form4_1746232243.xml","form_type":"4"}}],"next_cursor":"2025-05-03T00:30:49.000000Z,1160857"}